13 assets in Headache Disorder

Therapeutic assets addressing Headache Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dfn-11 (Sumatriptan Injection) Headache Disorder	Danish Headache Center	P4	BBB (75)
Lidocaine Headache Disorder	Daniel A Tonetti, MD	P4	BBB (75)
Marcaine Headache Disorder	HCA Florida North Florida Hospital	P4	BBB (73)
Amitriptyline Headache Disorder	Children's Hospital Medical Center, Cincinnati	P4	BB (70)
Dexasone Headache Disorder	Pain Medicine Department	P4	BB (70)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Headache Disorder	University Health Network, Toronto	P4	BB (69)
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer Headache Disorder	Beijing Tiantan Hospital	P4	BB (65)
Ibuprofen Headache Disorder	Humanis Saglık Anonim Sirketi	P3	BB (64)
Amylin Headache Disorder	Danish Headache Center	N/A	D (30)
Levcromakalim Headache Disorder	Danish Headache Center	N/A	D (30)